8Indexed trials
mesh condition
Hallucinations
Intelligence
Hallucinations intelligence: 8 indexed trials, 1 recruiting studies, 8 sponsors across 16 countries.
1Recruiting
8Sponsors
16Countries
Leading sponsors
Amsterdam UMC, location VUmc10 recruiting
Assistance Publique - Hôpitaux de Paris10 recruiting
Columbia University10 recruiting
Instituto de Investigacion Sanitaria INCLIVA10 recruiting
MapLight Therapeutics11 recruiting
National Institute of Mental Health (NIMH)10 recruiting
University Hospital, Caen10 recruiting
University of North Carolina, Chapel Hill10 recruiting
Geographic activity
United States4trials
France3trials
Canada1trials
Czechia1trials
Hungary1trials
Italy1trials
Netherlands1trials
Argentina1trials
Portugal1trials
Romania1trials
Serbia1trials
Slovakia1trials
Leading interventions
Citalopram1trials
ML-007C-MA1trials
Olanzapine1trials
Placebo (for rivastigmine)1trials
Placebo (sham coil) treatment1trials
Questionaries1trials
Quetiapine1trials
ReMindCare Intervention Group1trials
Repetitive Transcranial Magnetic Stimulation (rTMS)1trials
Risperidone1trials
Rivastigmine1trials
Sham stimulation1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.